Client-Sponsored Discovery & Engineering Projects
Various (Oncology, Immunology, Infectious Disease etc.)
Discovery/Pre-clinicalActive
Key Facts
Indication
Various (Oncology, Immunology, Infectious Disease etc.)
Phase
Discovery/Pre-clinical
Status
Active
Company
About Yumab
YUMAB is a specialized German contract research organization (CRO) and technology provider focused exclusively on therapeutic antibody discovery and development. Leveraging nearly 30 years of collective expertise and a proprietary, human-derived antibody library platform, the company offers end-to-end services from target identification to lead optimization, including antibody engineering and humanization. As a private, revenue-generating entity, YUMAB serves as a strategic partner for pharma and biotech companies, accelerating and de-risking their antibody drug development programs through flexible contract research agreements.
View full company profile